JP Morgan Chase’s Endo International plc ENDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-62,500
Closed -$484K 5716
2017
Q4
$484K Hold
62,500
﹤0.01% 4083
2017
Q3
$509K Hold
62,500
﹤0.01% 3822
2017
Q2
$698K Buy
+62,500
New +$734K ﹤0.01% 3594
2016
Q4
Sell
-3,700
Closed -$75K 5193
2016
Q3
$75K Buy
+3,700
New +$73.6K ﹤0.01% 3936
2016
Q2
Sell
-75,600
Closed -$2.13M 5045
2016
Q1
$2.13M Hold
75,600
﹤0.01% 2669
2015
Q4
$4.63M Buy
+75,600
New +$4.59M ﹤0.01% 2270
2015
Q3
Sell
-5,322
Closed -$424K 4144
2015
Q2
$424K Sell
5,322
-19,210
-78% -$1.66M ﹤0.01% 3614
2015
Q1
$2.2M Buy
24,532
+12,032
+96% +$1.01M ﹤0.01% 2818
2014
Q4
$902K Buy
+12,500
New +$856K ﹤0.01% 3403

Other funds holding ENDP

JP Morgan Chase's ENDP Position: Q3 2022 in Review

JP Morgan Chase sold out of Endo International plc (ENDP) in Q3 2022, closing a stake of 2,048,980 shares — an estimated $955K sold.

JP Morgan Chase first reported a position in ENDP in Q2 2013 and held it in 37 quarters. The position peaked at $122M in Q4 2015. 12 funds tracked by Wall St. Rank hold ENDP as of Q3 2022.

  • JP Morgan Chase reported no remaining Endo International plc position as of Q3 2022 after selling out during the quarter.
  • JP Morgan Chase sold 2,048,980 Endo International plc shares in Q3 2022, an estimated $955K.
  • JP Morgan Chase first reported a position in Endo International plc in Q2 2013 and held it in 37 quarters.
  • JP Morgan Chase's Endo International plc position peaked at $122M in Q4 2015.
  • 12 funds tracked by Wall St. Rank held Endo International plc as of Q3 2022.

Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.